Search

everythinglearnresearchcommunity

for

Search:↓

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Combination therapies work better than single treatments for hair loss.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Yoga helps manage PCOS symptoms and improves overall health.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Skin tags in obese individuals may indicate higher cardiovascular risk.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.